Main Stories – 第 52 页 – MicroVibeNews

Franklin Intermediate High Yield Municipal SMA Q3 2025 Commentary

Franklin Interme…

Fidelity Asset Manager Funds 50% Q3 2025 Commentary

Fidelity’s missi…

Fixed Income Portfolio Update: 5.5% Yield With Minimal Risk

Fixed Income Por…

Canada Packers: Canadian Pork At Just 4x EBITDA

Canada Packers: …

ClearBridge Large Cap Growth ESG Portfolios Q3 2025 Commentary

ClearBridge Larg…

Canopy Growth Is Making Big Moves In Its Cannabis Business (NASDAQ:CGC)

This article was…

The Full Impact Of Tariffs Is Imminent – December CPI Preview

The Full Impact …

Rio Tinto And Glencore: A Merger That Could Change The Investment Case

Rio Tinto And Gl…

Wall Street Week Ahead | Seeking Alpha

Listen on the go…

Altria: 7.5% Yield Is Underwritten By Cigarettes, Not Vapes And Oral Pouches (NYSE:MO)

This article was…

Week Ahead: Additional Scope For The U.S. Dollar To Extend The Upside Correction

Week Ahead: Addi…

Vale: Why Valuation Alone No Longer Makes This An Easy Buy (Rating Downgrade)

Vale: Why Valuat…

Tesla: The Elon Premium Is Off The Charts

Tesla: The Elon …

SA Quant Top 10 In 2026: A Focus On The AI Trade

SA Quant Top 10 …

Job Growth In Private Sector, Massive Job Losses At Federal & State Governments In H2 2025

Wolf Richter is …

Macy's: The Price Tag Is No Longer Worth The Risk (Rating Downgrade)

Macy's: The…

AI Reset Is Complete; Tech's Next Leg Starts Here

AI Reset Is Comp…

Carnival's Diversified Destinations Deliver Resilient Booking Trends – Rally Still Has Legs

Carnival's …

Dynagas LNG: A Speculative Long Position Could Be Justified

Dynagas LNG: A S…

Badger Meter: Deserving Of An Upgrade Following A Healthy Value Contraction (Rating Upgrade)

Badger Meter: De…

COMPASS Pathways plc (CMPS) Discusses Clinical Trial Plans for PTSD and Commercial Preparations for Treatment-Resistant Depression – Slideshow

COMPASS Pathways…

Lumexa Imaging: Resilient Demand With Compounding Scale Moat

Lumexa Imaging: …